AI summarySutton's Strategy and Resources Committee agreed to vary the London Cancer Hub lease, reducing the site sold to ACP and the capital receipt, with delegated authority to set final terms.
Written from the decision and the officer reportPDF Pro
OutcomeAgreedSite boundary reduced, new planning application enabled
MoneyCapital receipt reducedExact figures in exempt Appendix B
What happens nextMeanwhile use options to be consideredOpen space to be considered
Who it affectsLondon Cancer Hub and allotmentsSite sold to ACP, allotment area excluded
What was decided
The Committee agreed to vary the Agreement for Lease to allow the recommended site boundary change shown in Appendix A.
Authority was delegated to the Strategic Director of Resources and Section 151 Officer to negotiate and agree the detailed terms of the variation, using the financial terms in Appendix B.
Officers were asked to consider options for meanwhile use, with consideration given to open space.
Why
Reducing the physical size of the site sold to ACP allows land identified for potential allotment relocation to be excluded from the disposal. Report P5, P10
The variation will allow ACP to submit and pursue a revised planning application, while the council continues to safeguard land for future sustainable transport links to the Hub. Report P1, P10
The council is disposing of the site on a long leasehold basis under section 123 of the Local Government Act 1972, and must secure the best consideration reasonably obtainable. Report P11
What happens next
Gowling WLG will advise on the variation and report any legal risks to the Strategic Director before final terms are approved. Report P10, P13
Further independent expert advice from Avison Young will be sought as needed to protect the council's commercial interests in the Agreement for Lease. Report P11
Officers will look at options for meanwhile use of the site, with open space among the possibilities, and the existing allotments position is not covered by this report. Report P14
Options considered
Chosen: Vary the Agreement for Lease to reduce the site boundary and enable a revised planning application. Allows allotment land to be excluded and supports the revised development scheme Report P10
Chosen: Delegate authority to negotiate and agree the detailed terms. Enables the Strategic Director to finalise commercial and legal terms
Chosen: Consider options for meanwhile use, including open space. To make productive use of the site pending the revised development
Implications
Financial: The capital receipt from the site sale will be lower than originally agreed, though this reduction is already included in the council's wider financial plans. Report P5, P6
Legal: The disposal must comply with section 123 of the Local Government Act 1972 and the requirement to secure the best consideration reasonably obtainable. Report P11
Climate: No direct climate implications; the proposals keep a neutral environmental baseline and safeguard land for future sustainable transport links to the Hub. Report P1
Risk: No financial risks have been identified; legal risks will be reported by Gowling WLG before final terms are approved. Report P7, P8, P13
Who and where
ACP, the London Cancer Hub developer and buyer of the site Report P5, P10
London Borough of Sutton, as landowner disposing of the site on a long leasehold basis Report P11
Existing allotment holders, whose position is not covered by this report but whose potential relocation site is being excluded from the disposal Report P10, P14
Timeline
30/12/25: Legal comments provided by Amrita Chuhan, Assistant Head of Law, South London Legal Partnership Report P27
05/01/26: Finance comments provided by Victoria Goddard, Director of Finance Report P26
06/01/26: Equalities and Climate Impact Assessments signed off by Thuso Selelo, Director of Assets and Capital Delivery Report P30, P31
2026-02-16: Strategy and Resources Committee agreed the lease variation
Plain English for the jargon
Agreement for Lease (AfL): A contract setting out the terms under which a lease will be granted in the future, here covering the London Cancer Hub site disposal
ACP: The developer/buyer taking a long leasehold of the London Cancer Hub site from the council
Section 123, Local Government Act 1972: The council's power to dispose of land, requiring it to secure the best consideration reasonably obtainable
Meanwhile use: A temporary use of a site while its permanent development is being planned or progressed
What was decided, why, and what happens next
Pro reads every officer report for you and explains each decision in plain English: the money, the options, the risks, the timeline, each with the paragraph it came from.
Written by AI from the council's published papers. AI can get things wrong: the council's own wording below is the record.Report a problem
Item41
Resolved
That a variation of the Agreement for Lease be agreed, to allow for the recommended site boundary change as shown plan as set out at Appendix A That authority be delegated to the Strategic Director of Resources and Section 151 Officer to negotiate and agree the detailed terms of the variation based on the financial terms as summarised in Appendix B. 3. That Officers consider options for meanwhile use, with consideration given to open space.
Word for word from the decision Sutton published for this meeting.Source: moderngov.sutton.gov.uk
Page 249 Agenda Item 8 Update on London Cancer Hub
Report Title London Cancer Hub Update
Committee Strategy and Resources Committee
Meeting Date 16 February 2026
Chair Councillor Barry Lewis, Leader of the Council
Lead Member Councillor Sunita Gordon, Lead Member for Resources
Report From Richard Simpson, Strategic Director of Resources and Section 151 Officer
Report Author(s) Christopher Rhodes, Head of Asset Management
Ward(s) Affected Belmont
Ambitious for Sutton Strong and fair economic growth priorities
Open/Exempt Open with the exception of Appendix B which is considered exempt in accordance with paragraph s, Schedule 12 A of the Local Government Act 1972.
Signed Date 29 January 2026
1 Summary
1.1 This report provides an update for the Committee on progress on land lying to the east of Cotswold Road, Belmont, at the London Cancer Hub (LCH) - a £1bn development with ambitions to create a major new Centre of Excellence for cancer research on land owned by the Council in partnership with Aviva Capital Partners (ACP). The scheme has ambitious plans to deliver nearly one million square feet (90,000 sq. m.) of state-of-the-art research and laboratory space for life-sciences companies in Sutton, located next to leading life sciences companies and clinicians at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust.
1.2 The report recommends changes to the proposed land area being leased to ACP within the Agreement for Lease (AfL), in order to safeguard future development on the London Cancer Hub District site, specifically in relation to the potential need for future improvements to the highways network which may be required.
2 Recommendations
Report page 1 Agenda Item 8 Page 250 Update on London Cancer Hub
2.1 To agree to a variation of the Agreement for Lease to allow for the recommended site boundary change as shown on the attached plan.
2.2 To delegate authority to the Strategic Director of Resources and Section 151 Officer to negotiate and agree the detailed terms of the variation based on the financial terms [as summarised in the attached Exempt Appendix B].
3 Background and Key Information
3.1 The London Cancer Hub Partnership was created in 2013 between the London Borough of Sutton and the Institute of Cancer Research, supported by Royal Marsden NHS Foundation Trust, Greater London Authority, and Epsom and St Helier University Hospital NHS Trust. The aim was to deliver a global cancer hub at Belmont. The London Cancer Hub Development Framework for the entire campus published in 2016 envisaged over 280,000 square metres of modern facilities for cancer research and treatment and ancillaries.
3.2 In 2020/21, the Council secured £8.4m Strategic Investment Pot (SIP) grant funding to establish incubation space and carry out site clearance. The Innovation Gateway opened in 2021 as an incubator space for life sciences companies with offices and laboratories. In 2023 the Council secured a £14m Levelling-Up grant towards transport improvements, which will lead to the doubling of the number of trains to Belmont and improving access between the station and the campus.
3.3 In 2023, the Council again sought expressions of interest from investment partners. This successful process led to the Strategy and Resources Committee on 23 September 2023 approving the selection of Aviva Capital Partners (ACP) to develop the London Cancer Hub as a centre of excellence for cancer research, complementing adjacent facilities operated by partner organisations.
Read every report as text, not just the decision
Pro opens the officer report behind each decision, searchable and quotable, across every council we cover.
We use a cookie to keep you signed in and run your free-paper allowance, and an optional one to count visits. You can accept all, or choose. Privacy & cookies
Necessary
Keeps you signed in and runs your free-paper allowance. Always on.
Always on
Analytics
Counts visits and which pages are used. First-party only, no advertising, never shared.